

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | motile cilium assembly (GO:0044458) | 9.99596827 |
| 2 | epithelial cilium movement (GO:0003351) | 9.17050379 |
| 3 | axoneme assembly (GO:0035082) | 8.11513521 |
| 4 | sensory perception of smell (GO:0007608) | 7.17397192 |
| 5 | regulation of cilium movement (GO:0003352) | 6.51264450 |
| 6 | neuronal action potential propagation (GO:0019227) | 5.29011545 |
| 7 | protein neddylation (GO:0045116) | 5.28932717 |
| 8 | left/right pattern formation (GO:0060972) | 4.94302249 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 4.86450436 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.82330200 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.69757782 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.68256755 |
| 13 | vocalization behavior (GO:0071625) | 4.57555284 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.56645648 |
| 15 | left/right axis specification (GO:0070986) | 4.56441858 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.54247829 |
| 17 | glutamate secretion (GO:0014047) | 4.52089726 |
| 18 | vitamin transmembrane transport (GO:0035461) | 4.48809009 |
| 19 | ventricular system development (GO:0021591) | 4.41702153 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.40763517 |
| 21 | microtubule bundle formation (GO:0001578) | 4.31910520 |
| 22 | sensory perception of chemical stimulus (GO:0007606) | 4.28204195 |
| 23 | protein localization to synapse (GO:0035418) | 4.27792265 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.21173497 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16613357 |
| 26 | neuron recognition (GO:0008038) | 4.09048788 |
| 27 | cilium organization (GO:0044782) | 4.07157464 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.00984204 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95748528 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 3.94227376 |
| 31 | behavioral response to cocaine (GO:0048148) | 3.92241227 |
| 32 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.90777046 |
| 33 | axonal fasciculation (GO:0007413) | 3.89742681 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.84493806 |
| 35 | cilium assembly (GO:0042384) | 3.83670190 |
| 36 | lipoxygenase pathway (GO:0019372) | 3.81485712 |
| 37 | regulation of microtubule-based movement (GO:0060632) | 3.81119653 |
| 38 | tolerance induction (GO:0002507) | 3.80815154 |
| 39 | synaptic vesicle maturation (GO:0016188) | 3.78684551 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.78620302 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.78357109 |
| 42 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.77336324 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.74179249 |
| 44 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.73086474 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.70870639 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.68527147 |
| 47 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.67315531 |
| 48 | regulation of vesicle fusion (GO:0031338) | 3.67179844 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 3.64760845 |
| 50 | neurotransmitter secretion (GO:0007269) | 3.61438670 |
| 51 | primary alcohol catabolic process (GO:0034310) | 3.58338495 |
| 52 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.58078016 |
| 53 | cerebellar granule cell differentiation (GO:0021707) | 3.55342412 |
| 54 | microtubule depolymerization (GO:0007019) | 3.54262596 |
| 55 | protein localization to cilium (GO:0061512) | 3.54026885 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.53014156 |
| 57 | regulation of germinal center formation (GO:0002634) | 3.52807230 |
| 58 | intraciliary transport (GO:0042073) | 3.49296630 |
| 59 | negative regulation of heart rate (GO:0010459) | 3.45091231 |
| 60 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.44823414 |
| 61 | retinal cone cell development (GO:0046549) | 3.40857987 |
| 62 | layer formation in cerebral cortex (GO:0021819) | 3.37302461 |
| 63 | detection of calcium ion (GO:0005513) | 3.36935471 |
| 64 | regulation of protein kinase A signaling (GO:0010738) | 3.32552724 |
| 65 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.31179367 |
| 66 | blood coagulation, intrinsic pathway (GO:0007597) | 3.28236397 |
| 67 | presynaptic membrane organization (GO:0097090) | 3.28216161 |
| 68 | activation of protein kinase A activity (GO:0034199) | 3.26357547 |
| 69 | regulation of platelet activation (GO:0010543) | 3.25934162 |
| 70 | synaptic vesicle endocytosis (GO:0048488) | 3.24056903 |
| 71 | regulation of platelet aggregation (GO:0090330) | 3.23227242 |
| 72 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.22795759 |
| 73 | diterpenoid biosynthetic process (GO:0016102) | 3.19994118 |
| 74 | response to amphetamine (GO:0001975) | 3.19960275 |
| 75 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.19811279 |
| 76 | cell migration in hindbrain (GO:0021535) | 3.19648003 |
| 77 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.19203167 |
| 78 | regulation of interleukin-13 production (GO:0032656) | 3.17051462 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.15627437 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.14733880 |
| 81 | response to xenobiotic stimulus (GO:0009410) | 3.14107572 |
| 82 | positive regulation of synapse maturation (GO:0090129) | 3.13802983 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 3.13700565 |
| 84 | neurotransmitter transport (GO:0006836) | 3.11090629 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 3.10862403 |
| 86 | ethanol metabolic process (GO:0006067) | 3.10675376 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10628097 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10628097 |
| 89 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.10238440 |
| 90 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.08923645 |
| 91 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08603102 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.07098693 |
| 93 | postsynaptic membrane organization (GO:0001941) | 3.06225866 |
| 94 | mating behavior (GO:0007617) | 3.06130525 |
| 95 | retinal rod cell development (GO:0046548) | 3.05534802 |
| 96 | negative regulation of appetite (GO:0032099) | 3.02830639 |
| 97 | negative regulation of response to food (GO:0032096) | 3.02830639 |
| 98 | long-term memory (GO:0007616) | 3.02655410 |
| 99 | microtubule-based movement (GO:0007018) | 3.02328340 |
| 100 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.02293479 |
| 101 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.00293398 |
| 102 | high-density lipoprotein particle remodeling (GO:0034375) | 2.99171051 |
| 103 | sperm motility (GO:0030317) | 2.99125055 |
| 104 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98511967 |
| 105 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.97988754 |
| 106 | one-carbon compound transport (GO:0019755) | 2.97743706 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 2.97306763 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96841817 |
| 109 | protein insertion into membrane (GO:0051205) | 2.96561303 |
| 110 | regulation of cell communication by electrical coupling (GO:0010649) | 2.95690951 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95609577 |
| 112 | regulation of synapse maturation (GO:0090128) | 2.94830368 |
| 113 | regulation of synapse structural plasticity (GO:0051823) | 2.94504531 |
| 114 | cell projection assembly (GO:0030031) | 2.94199099 |
| 115 | positive regulation of membrane potential (GO:0045838) | 2.92958297 |
| 116 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.91551214 |
| 117 | long-term synaptic potentiation (GO:0060291) | 2.91394485 |
| 118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.90749589 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.90749451 |
| 120 | dopamine receptor signaling pathway (GO:0007212) | 2.90669574 |
| 121 | centriole assembly (GO:0098534) | 2.89762094 |
| 122 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89613611 |
| 123 | negative regulation of norepinephrine secretion (GO:0010700) | 2.88737935 |
| 124 | L-ascorbic acid metabolic process (GO:0019852) | 2.87693166 |
| 125 | neutrophil activation (GO:0042119) | 2.85849702 |
| 126 | photoreceptor cell maintenance (GO:0045494) | 2.85025671 |
| 127 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.84617150 |
| 128 | synaptic transmission, dopaminergic (GO:0001963) | 2.84548084 |
| 129 | cellular response to electrical stimulus (GO:0071257) | 2.84532613 |
| 130 | membrane depolarization during action potential (GO:0086010) | 2.84493124 |
| 131 | positive regulation of dendritic spine development (GO:0060999) | 2.83945331 |
| 132 | locomotory exploration behavior (GO:0035641) | 2.83723369 |
| 133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.83326376 |
| 134 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.82972596 |
| 135 | regulation of synaptic plasticity (GO:0048167) | 2.82920316 |
| 136 | membrane depolarization (GO:0051899) | 2.82839089 |
| 137 | regulation of dendritic spine development (GO:0060998) | 2.82279291 |
| 138 | negative regulation of microtubule polymerization (GO:0031115) | 2.81982296 |
| 139 | response to histamine (GO:0034776) | 2.81966660 |
| 140 | reverse cholesterol transport (GO:0043691) | 2.80780730 |
| 141 | positive regulation of action potential (GO:0045760) | 2.78209868 |
| 142 | membrane hyperpolarization (GO:0060081) | 2.76784620 |
| 143 | rhodopsin mediated signaling pathway (GO:0016056) | 2.75866268 |
| 144 | glutathione derivative biosynthetic process (GO:1901687) | 2.75833129 |
| 145 | glutathione derivative metabolic process (GO:1901685) | 2.75833129 |
| 146 | adenosine receptor signaling pathway (GO:0001973) | 2.75534993 |
| 147 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.74458487 |
| 148 | ATP synthesis coupled proton transport (GO:0015986) | 2.74458487 |
| 149 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.74406748 |
| 150 | exploration behavior (GO:0035640) | 2.74190081 |
| 151 | response to pheromone (GO:0019236) | 2.72970116 |
| 152 | regulation of neurotransmitter levels (GO:0001505) | 2.72678581 |
| 153 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.72480356 |
| 154 | synaptic transmission (GO:0007268) | 2.72264209 |
| 155 | cardiolipin metabolic process (GO:0032048) | 2.71913580 |
| 156 | protein polyglutamylation (GO:0018095) | 2.71042612 |
| 157 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.70829790 |
| 158 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.70767870 |
| 159 | retinol metabolic process (GO:0042572) | 2.70576741 |
| 160 | mechanosensory behavior (GO:0007638) | 2.69755491 |
| 161 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.69647786 |
| 162 | potassium ion transmembrane transport (GO:0071805) | 2.69205698 |
| 163 | cellular potassium ion transport (GO:0071804) | 2.69205698 |
| 164 | negative regulation of platelet activation (GO:0010544) | 2.66833949 |
| 165 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.66777151 |
| 166 | cilium morphogenesis (GO:0060271) | 2.65326538 |
| 167 | platelet aggregation (GO:0070527) | 2.65072365 |
| 168 | negative regulation of neurotransmitter transport (GO:0051589) | 2.64200288 |
| 169 | regulation of megakaryocyte differentiation (GO:0045652) | 2.64168647 |
| 170 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.63709861 |
| 171 | L-phenylalanine catabolic process (GO:0006559) | 2.63709861 |
| 172 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.62560625 |
| 173 | regulation of memory T cell differentiation (GO:0043380) | 2.62355387 |
| 174 | phospholipid homeostasis (GO:0055091) | 2.61886808 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.61621690 |
| 176 | microtubule polymerization or depolymerization (GO:0031109) | 2.61425362 |
| 177 | androgen biosynthetic process (GO:0006702) | 2.58658065 |
| 178 | negative regulation of protein localization to cell surface (GO:2000009) | 2.55453091 |
| 179 | regulation of female receptivity (GO:0045924) | 2.54638077 |
| 180 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.54547650 |
| 181 | beta-amyloid metabolic process (GO:0050435) | 2.52747116 |
| 182 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.52648505 |
| 183 | exogenous drug catabolic process (GO:0042738) | 2.52536800 |
| 184 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.50988151 |
| 185 | positive regulation of tolerance induction (GO:0002645) | 2.48296215 |
| 186 | glutathione metabolic process (GO:0006749) | 2.47221761 |
| 187 | multicellular organism reproduction (GO:0032504) | 2.46627568 |
| 188 | termination of signal transduction (GO:0023021) | 2.44815997 |
| 189 | ADP metabolic process (GO:0046031) | 2.44784556 |
| 190 | regulation of interleukin-5 production (GO:0032674) | 2.42788081 |
| 191 | sleep (GO:0030431) | 2.40133698 |
| 192 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.38977652 |
| 193 | dopamine transport (GO:0015872) | 2.38488799 |
| 194 | negative regulation of humoral immune response (GO:0002921) | 2.37233909 |
| 195 | ethanol oxidation (GO:0006069) | 2.36677828 |
| 196 | axonemal dynein complex assembly (GO:0070286) | 13.3493642 |
| 197 | cilium or flagellum-dependent cell motility (GO:0001539) | 13.1210689 |
| 198 | cilium movement (GO:0003341) | 10.8595042 |
| 199 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 10.7079045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.52719889 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.96275450 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.94374742 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89952401 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86330086 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.78852694 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52868518 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52868518 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.52078383 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51580736 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48231449 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41671459 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39841873 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35796875 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27345355 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24162712 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22815280 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21416066 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17612187 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17081498 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.15860148 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09875392 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08488084 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06273341 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05986992 |
| 26 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.04597295 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.99412336 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98671267 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98426982 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94983345 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94887819 |
| 32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.94723590 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.93849520 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92034499 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88716319 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86704067 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84926229 |
| 38 | GATA2_19941826_ChIP-Seq_K562_Human | 1.84237509 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83784351 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79297311 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77967162 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77857557 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.77083113 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72382527 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69677028 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68342370 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67281236 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66037315 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.63867136 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62260415 |
| 51 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60064600 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59795994 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59562084 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59309461 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59151909 |
| 56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.58950710 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58742178 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55671684 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55064495 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54986672 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54411646 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53858310 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53141723 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51686184 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50470144 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50280861 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48196117 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47834267 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.47369496 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46261006 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.45792067 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45762107 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44706514 |
| 74 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44694115 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40699615 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38344278 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37216546 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.35372724 |
| 79 | AR_20517297_ChIP-Seq_VCAP_Human | 1.34884723 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34515995 |
| 81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.33309956 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32528464 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.31493200 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28934026 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28536181 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28536181 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26897414 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26743669 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26743669 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26491048 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26280284 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26145467 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25305182 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25068810 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24748078 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24741984 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24282223 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24076155 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23461514 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23043224 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22445565 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22307899 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21154642 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21002365 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20594051 |
| 106 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.20512969 |
| 107 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20137396 |
| 108 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18254058 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17935242 |
| 110 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17922656 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16548631 |
| 112 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.15214446 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15113372 |
| 114 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14762313 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14178731 |
| 116 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13667964 |
| 117 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13609668 |
| 118 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13609668 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13574288 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13109506 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.12966512 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.12605388 |
| 123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12465140 |
| 124 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.12407513 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11986515 |
| 126 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11702379 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11670703 |
| 128 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.11573386 |
| 129 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.10433440 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10175079 |
| 131 | JUN_21703547_ChIP-Seq_K562_Human | 1.10149986 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09207919 |
| 133 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.09124151 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08909414 |
| 135 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08684340 |
| 136 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08684340 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06368889 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06328800 |
| 139 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06146039 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05548893 |
| 141 | NFYA_21822215_ChIP-Seq_K562_Human | 1.05489665 |
| 142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05137077 |
| 143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04975753 |
| 144 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04871263 |
| 145 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04589015 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04509222 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04337208 |
| 148 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04270968 |
| 149 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.03819421 |
| 150 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03441690 |
| 151 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03228723 |
| 152 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02936818 |
| 153 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02337089 |
| 154 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01736803 |
| 155 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01526343 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01448790 |
| 157 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00606923 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 0.99362299 |
| 159 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99314337 |
| 160 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99044262 |
| 161 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98736992 |
| 162 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98486948 |
| 163 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98267251 |
| 164 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97133183 |
| 165 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95879390 |
| 166 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93395510 |
| 167 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93151823 |
| 168 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91003186 |
| 169 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87937255 |
| 170 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87934002 |
| 171 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87437551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.45307756 |
| 2 | MP0001984_abnormal_olfaction | 5.09788764 |
| 3 | MP0005083_abnormal_biliary_tract | 4.79083539 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 4.70713819 |
| 5 | MP0003880_abnormal_central_pattern | 4.50903368 |
| 6 | MP0002132_abnormal_respiratory_system | 3.69342650 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55721772 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.55145963 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 3.12744661 |
| 10 | MP0004270_analgesia | 3.05393936 |
| 11 | MP0009745_abnormal_behavioral_response | 3.04198510 |
| 12 | MP0003724_increased_susceptibility_to | 2.91446253 |
| 13 | MP0003011_delayed_dark_adaptation | 2.86101765 |
| 14 | MP0002064_seizures | 2.85861935 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.81019976 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.67927568 |
| 17 | MP0009046_muscle_twitch | 2.64745294 |
| 18 | MP0002272_abnormal_nervous_system | 2.58626471 |
| 19 | MP0001486_abnormal_startle_reflex | 2.52846874 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.48733379 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.43949237 |
| 22 | MP0005365_abnormal_bile_salt | 2.32562904 |
| 23 | MP0002184_abnormal_innervation | 2.29316117 |
| 24 | MP0000383_abnormal_hair_follicle | 2.21586105 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.21040209 |
| 26 | MP0004043_abnormal_pH_regulation | 2.18422534 |
| 27 | MP0002736_abnormal_nociception_after | 2.11230432 |
| 28 | MP0001188_hyperpigmentation | 2.06446381 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.05826943 |
| 30 | MP0006276_abnormal_autonomic_nervous | 2.03448336 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.99866668 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.97142959 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.94423873 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.93921032 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.93311097 |
| 36 | MP0000778_abnormal_nervous_system | 1.91722641 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.86862467 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.86323074 |
| 39 | MP0001905_abnormal_dopamine_level | 1.85225268 |
| 40 | MP0003195_calcinosis | 1.83871533 |
| 41 | MP0000230_abnormal_systemic_arterial | 1.83696501 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.76133202 |
| 43 | MP0005410_abnormal_fertilization | 1.75502256 |
| 44 | MP0010678_abnormal_skin_adnexa | 1.71204565 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.70499696 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.68911856 |
| 47 | MP0001970_abnormal_pain_threshold | 1.68877625 |
| 48 | MP0003303_peritoneal_inflammation | 1.67425963 |
| 49 | MP0001765_abnormal_ion_homeostasis | 1.66249913 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.65082667 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.63941211 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.62735071 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.61727507 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.61613380 |
| 55 | MP0008872_abnormal_physiological_respon | 1.60540237 |
| 56 | MP0000955_abnormal_spinal_cord | 1.57010689 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.56148489 |
| 58 | MP0003329_amyloid_beta_deposits | 1.53793904 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.53775347 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.53112253 |
| 61 | MP0003122_maternal_imprinting | 1.51732431 |
| 62 | MP0001529_abnormal_vocalization | 1.51596537 |
| 63 | MP0003787_abnormal_imprinting | 1.47857206 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.47093103 |
| 65 | MP0004924_abnormal_behavior | 1.47093103 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.46890960 |
| 67 | MP0002822_catalepsy | 1.40013595 |
| 68 | MP0003718_maternal_effect | 1.36827979 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.36424235 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.35902178 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.35348051 |
| 72 | MP0003638_abnormal_response/metabolism_ | 1.33753195 |
| 73 | MP0002752_abnormal_somatic_nervous | 1.32953720 |
| 74 | MP0003828_pulmonary_edema | 1.32849883 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.32417300 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.30111872 |
| 77 | MP0000343_altered_response_to | 1.29219310 |
| 78 | MP0002229_neurodegeneration | 1.26710785 |
| 79 | MP0000751_myopathy | 1.26685290 |
| 80 | MP0004142_abnormal_muscle_tone | 1.26097011 |
| 81 | MP0004484_altered_response_of | 1.24618670 |
| 82 | MP0003866_abnormal_defecation | 1.23826828 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 1.22485530 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.21951624 |
| 85 | MP0002234_abnormal_pharynx_morphology | 1.19268260 |
| 86 | MP0008569_lethality_at_weaning | 1.18000873 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.17514807 |
| 88 | MP0002152_abnormal_brain_morphology | 1.16141656 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 1.15007065 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.14684115 |
| 91 | MP0005000_abnormal_immune_tolerance | 1.12423903 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.10623301 |
| 93 | MP0008775_abnormal_heart_ventricle | 1.09358901 |
| 94 | MP0001663_abnormal_digestive_system | 1.09193445 |
| 95 | MP0005409_darkened_coat_color | 1.08913631 |
| 96 | MP0009643_abnormal_urine_homeostasis | 1.08583056 |
| 97 | MP0004085_abnormal_heartbeat | 1.07991987 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 1.07317827 |
| 99 | MP0003252_abnormal_bile_duct | 1.06347693 |
| 100 | MP0005394_taste/olfaction_phenotype | 1.06233333 |
| 101 | MP0005499_abnormal_olfactory_system | 1.06233333 |
| 102 | MP0009763_increased_sensitivity_to | 1.06171616 |
| 103 | MP0004133_heterotaxia | 1.05818579 |
| 104 | MP0003879_abnormal_hair_cell | 1.04956327 |
| 105 | MP0004742_abnormal_vestibular_system | 1.03805282 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.99975837 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.99795019 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.97244284 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.97028101 |
| 110 | MP0004858_abnormal_nervous_system | 0.94662157 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.93812278 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.93702975 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.93429755 |
| 114 | MP0002102_abnormal_ear_morphology | 0.93242037 |
| 115 | MP0000249_abnormal_blood_vessel | 0.92899775 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.90980027 |
| 117 | MP0001545_abnormal_hematopoietic_system | 0.89808169 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.89808169 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.89720581 |
| 120 | MP0001664_abnormal_digestion | 0.89627910 |
| 121 | MP0003631_nervous_system_phenotype | 0.89627748 |
| 122 | MP0004883_abnormal_blood_vessel | 0.89251116 |
| 123 | MP0005165_increased_susceptibility_to | 0.88398023 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.87672177 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.87651783 |
| 126 | MP0006292_abnormal_olfactory_placode | 0.87322497 |
| 127 | MP0003633_abnormal_nervous_system | 0.87012765 |
| 128 | MP0005253_abnormal_eye_physiology | 0.86861498 |
| 129 | MP0004947_skin_inflammation | 0.86293401 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.85973928 |
| 131 | MP0005395_other_phenotype | 0.85062619 |
| 132 | MP0002723_abnormal_immune_serum | 0.84773422 |
| 133 | MP0002127_abnormal_cardiovascular_syste | 0.84673097 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.84528041 |
| 135 | MP0001756_abnormal_urination | 0.83802186 |
| 136 | MP0003136_yellow_coat_color | 0.83650213 |
| 137 | MP0001800_abnormal_humoral_immune | 0.82889898 |
| 138 | MP0003632_abnormal_nervous_system | 0.82494725 |
| 139 | MP0002452_abnormal_antigen_presenting | 0.81924453 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.81738818 |
| 141 | MP0002405_respiratory_system_inflammati | 0.81359729 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.80426077 |
| 143 | MP0008004_abnormal_stomach_pH | 0.79942801 |
| 144 | MP0001177_atelectasis | 0.79765136 |
| 145 | MP0000631_abnormal_neuroendocrine_gland | 0.79685688 |
| 146 | MP0003634_abnormal_glial_cell | 0.79613914 |
| 147 | MP0004147_increased_porphyrin_level | 0.79148109 |
| 148 | MP0005195_abnormal_posterior_eye | 0.77499622 |
| 149 | MP0005310_abnormal_salivary_gland | 0.77473239 |
| 150 | MP0005164_abnormal_response_to | 0.77106297 |
| 151 | MP0004130_abnormal_muscle_cell | 0.76912748 |
| 152 | MP0002090_abnormal_vision | 0.76614301 |
| 153 | MP0003566_abnormal_cell_adhesion | 0.75447448 |
| 154 | MP0005671_abnormal_response_to | 0.74763425 |
| 155 | MP0003646_muscle_fatigue | 0.74478025 |
| 156 | MP0003121_genomic_imprinting | 0.74036259 |
| 157 | MP0009379_abnormal_foot_pigmentation | 0.73372392 |
| 158 | MP0001502_abnormal_circadian_rhythm | 0.73092726 |
| 159 | MP0003698_abnormal_male_reproductive | 0.72884750 |
| 160 | MP0001929_abnormal_gametogenesis | 0.71961071 |
| 161 | MP0003861_abnormal_nervous_system | 0.71736639 |
| 162 | MP0010234_abnormal_vibrissa_follicle | 0.70997031 |
| 163 | MP0008877_abnormal_DNA_methylation | 0.70705146 |
| 164 | MP0000026_abnormal_inner_ear | 0.70345893 |
| 165 | MP0002751_abnormal_autonomic_nervous | 0.69405545 |
| 166 | MP0003123_paternal_imprinting | 0.69218280 |
| 167 | MP0008874_decreased_physiological_sensi | 0.68923074 |
| 168 | MP0002069_abnormal_eating/drinking_beha | 0.68838395 |
| 169 | MP0004084_abnormal_cardiac_muscle | 0.68478038 |
| 170 | MP0002332_abnormal_exercise_endurance | 0.68203497 |
| 171 | MP0001851_eye_inflammation | 0.67918581 |
| 172 | MP0003137_abnormal_impulse_conducting | 0.67826688 |
| 173 | MP0003436_decreased_susceptibility_to | 0.67690726 |
| 174 | MP0001790_abnormal_immune_system | 0.65582388 |
| 175 | MP0005387_immune_system_phenotype | 0.65582388 |
| 176 | MP0009764_decreased_sensitivity_to | 0.64680680 |
| 177 | MP0005623_abnormal_meninges_morphology | 0.64553988 |
| 178 | MP0002139_abnormal_hepatobiliary_system | 0.63803837 |
| 179 | MP0002160_abnormal_reproductive_system | 0.63561691 |
| 180 | MP0005025_abnormal_response_to | 0.62708084 |
| 181 | MP0002419_abnormal_innate_immunity | 0.61898967 |
| 182 | MP0002398_abnormal_bone_marrow | 0.60714800 |
| 183 | MP0002168_other_aberrant_phenotype | 0.58967393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bronchiectasis (HP:0002110) | 6.09018864 |
| 2 | Focal motor seizures (HP:0011153) | 5.82448371 |
| 3 | Nasal polyposis (HP:0100582) | 5.39504858 |
| 4 | Atonic seizures (HP:0010819) | 5.08636928 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.80372029 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.53718017 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.49750221 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 4.48144660 |
| 9 | Febrile seizures (HP:0002373) | 4.35157970 |
| 10 | Focal seizures (HP:0007359) | 4.20253986 |
| 11 | Limb dystonia (HP:0002451) | 4.13588320 |
| 12 | Menorrhagia (HP:0000132) | 4.00181495 |
| 13 | Absence seizures (HP:0002121) | 3.89827541 |
| 14 | Recurrent sinusitis (HP:0011108) | 3.87144401 |
| 15 | Myokymia (HP:0002411) | 3.85273021 |
| 16 | Bronchitis (HP:0012387) | 3.80095292 |
| 17 | Infertility (HP:0000789) | 3.79772875 |
| 18 | Purpura (HP:0000979) | 3.68282729 |
| 19 | Increased mean platelet volume (HP:0011877) | 3.68016246 |
| 20 | Chronic sinusitis (HP:0011109) | 3.67770012 |
| 21 | Male infertility (HP:0003251) | 3.65372075 |
| 22 | Petechiae (HP:0000967) | 3.57478233 |
| 23 | Retinal dysplasia (HP:0007973) | 3.38991811 |
| 24 | Abnormal platelet volume (HP:0011876) | 3.38551348 |
| 25 | Dialeptic seizures (HP:0011146) | 3.36047291 |
| 26 | Hyperventilation (HP:0002883) | 3.33493956 |
| 27 | Rhinitis (HP:0012384) | 3.25632061 |
| 28 | Visual hallucinations (HP:0002367) | 3.15774930 |
| 29 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.05074694 |
| 30 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.02885700 |
| 31 | Epistaxis (HP:0000421) | 3.02541865 |
| 32 | Chronic otitis media (HP:0000389) | 3.00681269 |
| 33 | Abnormality of macular pigmentation (HP:0008002) | 2.89712760 |
| 34 | Insidious onset (HP:0003587) | 2.87527120 |
| 35 | Termporal pattern (HP:0011008) | 2.87527120 |
| 36 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.86254534 |
| 37 | Recurrent otitis media (HP:0000403) | 2.84089354 |
| 38 | Broad-based gait (HP:0002136) | 2.83265248 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 2.80354394 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 2.77920317 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.77657826 |
| 42 | Hyperactive renin-angiotensin system (HP:0000841) | 2.72232329 |
| 43 | Generalized tonic-clonic seizures (HP:0002069) | 2.69809099 |
| 44 | Gait imbalance (HP:0002141) | 2.69481137 |
| 45 | Hyperthyroidism (HP:0000836) | 2.67600970 |
| 46 | Chronic hepatic failure (HP:0100626) | 2.64510086 |
| 47 | Pheochromocytoma (HP:0002666) | 2.63320561 |
| 48 | Tubulointerstitial nephritis (HP:0001970) | 2.62820285 |
| 49 | Amblyopia (HP:0000646) | 2.57117816 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.56890670 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.53225386 |
| 52 | Progressive macrocephaly (HP:0004481) | 2.52952225 |
| 53 | True hermaphroditism (HP:0010459) | 2.52801973 |
| 54 | Progressive inability to walk (HP:0002505) | 2.48356269 |
| 55 | Chronic bronchitis (HP:0004469) | 2.48225839 |
| 56 | Neuroendocrine neoplasm (HP:0100634) | 2.48105398 |
| 57 | Pancreatic cysts (HP:0001737) | 2.43421004 |
| 58 | Syncope (HP:0001279) | 2.41787260 |
| 59 | Gingival bleeding (HP:0000225) | 2.39351114 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.38162019 |
| 61 | Acanthocytosis (HP:0001927) | 2.37766506 |
| 62 | Nephronophthisis (HP:0000090) | 2.37387015 |
| 63 | Anxiety (HP:0000739) | 2.35471906 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.34506641 |
| 65 | Occipital encephalocele (HP:0002085) | 2.32125306 |
| 66 | Agitation (HP:0000713) | 2.30450205 |
| 67 | Depression (HP:0000716) | 2.29961440 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.28434224 |
| 69 | Abnormal ciliary motility (HP:0012262) | 2.27780404 |
| 70 | Abnormality of the corticospinal tract (HP:0002492) | 2.26502956 |
| 71 | Split foot (HP:0001839) | 2.26097608 |
| 72 | Narrow nasal bridge (HP:0000446) | 2.25900733 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.25541277 |
| 74 | Decreased central vision (HP:0007663) | 2.25342635 |
| 75 | Drooling (HP:0002307) | 2.24500198 |
| 76 | Excessive salivation (HP:0003781) | 2.24500198 |
| 77 | Delusions (HP:0000746) | 2.23483105 |
| 78 | Central scotoma (HP:0000603) | 2.23395440 |
| 79 | Truncal ataxia (HP:0002078) | 2.21262478 |
| 80 | Mutism (HP:0002300) | 2.19600667 |
| 81 | Absent speech (HP:0001344) | 2.19087826 |
| 82 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.16658628 |
| 83 | Sensory axonal neuropathy (HP:0003390) | 2.15141463 |
| 84 | Failure to thrive in infancy (HP:0001531) | 2.14748372 |
| 85 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.14363046 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.14363046 |
| 87 | Optic disc pallor (HP:0000543) | 2.14213074 |
| 88 | Dysmetria (HP:0001310) | 2.13293705 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 2.12582068 |
| 90 | Inability to walk (HP:0002540) | 2.12421887 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 2.11889406 |
| 92 | Mitochondrial inheritance (HP:0001427) | 2.11191640 |
| 93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.11175392 |
| 94 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.11175392 |
| 95 | Congenital stationary night blindness (HP:0007642) | 2.09567024 |
| 96 | Abnormal hair whorl (HP:0010721) | 2.09257133 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09143677 |
| 98 | Impaired platelet aggregation (HP:0003540) | 2.08232437 |
| 99 | Abnormal platelet function (HP:0011869) | 2.08232437 |
| 100 | Dyschromatopsia (HP:0007641) | 2.04127946 |
| 101 | Poikilocytosis (HP:0004447) | 2.02694575 |
| 102 | Specific learning disability (HP:0001328) | 2.01978580 |
| 103 | Stereotypic behavior (HP:0000733) | 2.01858653 |
| 104 | Cystic liver disease (HP:0006706) | 2.01388225 |
| 105 | Recurrent bronchitis (HP:0002837) | 2.01080109 |
| 106 | Acute encephalopathy (HP:0006846) | 1.99556792 |
| 107 | Cerebral hypomyelination (HP:0006808) | 1.98896466 |
| 108 | Ventricular fibrillation (HP:0001663) | 1.97465040 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 1.97068044 |
| 110 | Protruding tongue (HP:0010808) | 1.96291874 |
| 111 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96252857 |
| 112 | Dysdiadochokinesis (HP:0002075) | 1.96226598 |
| 113 | Methylmalonic acidemia (HP:0002912) | 1.94367788 |
| 114 | Cerebral inclusion bodies (HP:0100314) | 1.93647873 |
| 115 | Hypsarrhythmia (HP:0002521) | 1.92495170 |
| 116 | Inappropriate behavior (HP:0000719) | 1.91441355 |
| 117 | Genital tract atresia (HP:0001827) | 1.91148155 |
| 118 | Choroideremia (HP:0001139) | 1.90064826 |
| 119 | Calf muscle hypertrophy (HP:0008981) | 1.90025449 |
| 120 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87939926 |
| 121 | Focal dystonia (HP:0004373) | 1.87721862 |
| 122 | Vaginal atresia (HP:0000148) | 1.87001557 |
| 123 | Hypoventilation (HP:0002791) | 1.86222265 |
| 124 | Absent/shortened dynein arms (HP:0200106) | 1.85570799 |
| 125 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.85570799 |
| 126 | Neurofibrillary tangles (HP:0002185) | 1.85415291 |
| 127 | Postural instability (HP:0002172) | 1.83685580 |
| 128 | Dysphonia (HP:0001618) | 1.83163717 |
| 129 | Abnormal eating behavior (HP:0100738) | 1.81831807 |
| 130 | Atelectasis (HP:0100750) | 1.81536701 |
| 131 | Polyphagia (HP:0002591) | 1.81169796 |
| 132 | Torticollis (HP:0000473) | 1.81023229 |
| 133 | Progressive external ophthalmoplegia (HP:0000590) | 1.80233197 |
| 134 | Abnormality of midbrain morphology (HP:0002418) | 1.80219309 |
| 135 | Molar tooth sign on MRI (HP:0002419) | 1.80219309 |
| 136 | Abnormal pupillary function (HP:0007686) | 1.79863459 |
| 137 | Palpitations (HP:0001962) | 1.78905356 |
| 138 | Action tremor (HP:0002345) | 1.77283345 |
| 139 | Male pseudohermaphroditism (HP:0000037) | 1.71125836 |
| 140 | Abnormality of the renal cortex (HP:0011035) | 1.68184956 |
| 141 | Congenital hepatic fibrosis (HP:0002612) | 1.67406973 |
| 142 | Joint swelling (HP:0001386) | 1.65759853 |
| 143 | Abnormality of renin-angiotensin system (HP:0000847) | 1.63754865 |
| 144 | Postaxial foot polydactyly (HP:0001830) | 1.59545854 |
| 145 | Nephropathy (HP:0000112) | 1.58443244 |
| 146 | Renal salt wasting (HP:0000127) | 1.57343925 |
| 147 | Hyperaldosteronism (HP:0000859) | 1.57174510 |
| 148 | Hyperkalemia (HP:0002153) | 1.55607895 |
| 149 | Hypophosphatemic rickets (HP:0004912) | 1.50435447 |
| 150 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.49622061 |
| 151 | Hypokalemic alkalosis (HP:0001949) | 1.47566214 |
| 152 | Median cleft lip (HP:0000161) | 1.45826075 |
| 153 | Tubular atrophy (HP:0000092) | 1.44400228 |
| 154 | Paralysis (HP:0003470) | 1.44197299 |
| 155 | Xanthomatosis (HP:0000991) | 1.38698617 |
| 156 | Cone-rod dystrophy (HP:0000548) | 1.38292213 |
| 157 | Tubulointerstitial abnormality (HP:0001969) | 1.38246288 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.38213126 |
| 159 | Stomatitis (HP:0010280) | 1.36277160 |
| 160 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.34130548 |
| 161 | Polydipsia (HP:0001959) | 1.33404784 |
| 162 | Abnormal drinking behavior (HP:0030082) | 1.33404784 |
| 163 | Oculomotor apraxia (HP:0000657) | 1.32492793 |
| 164 | Azoospermia (HP:0000027) | 1.31475711 |
| 165 | Abnormality of chloride homeostasis (HP:0011422) | 1.31132045 |
| 166 | Anencephaly (HP:0002323) | 1.30513304 |
| 167 | Conjunctival telangiectasia (HP:0000524) | 1.29907100 |
| 168 | Abnormal spermatogenesis (HP:0008669) | 1.29714889 |
| 169 | Abnormality of iron homeostasis (HP:0011031) | 1.28713304 |
| 170 | Furrowed tongue (HP:0000221) | 1.26973403 |
| 171 | Vascular calcification (HP:0004934) | 1.25953125 |
| 172 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.24259770 |
| 173 | Spontaneous hematomas (HP:0007420) | 1.24005234 |
| 174 | Bell-shaped thorax (HP:0001591) | 1.21131219 |
| 175 | Stage 5 chronic kidney disease (HP:0003774) | 1.19472864 |
| 176 | Portal hypertension (HP:0001409) | 1.19428183 |
| 177 | Renal cortical cysts (HP:0000803) | 1.18255820 |
| 178 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.17740575 |
| 179 | Postaxial hand polydactyly (HP:0001162) | 1.17174172 |
| 180 | Bruising susceptibility (HP:0000978) | 1.16701526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 7.03702020 |
| 2 | MAPK15 | 4.62474208 |
| 3 | CASK | 4.11397278 |
| 4 | TAOK3 | 3.84815404 |
| 5 | MAP3K4 | 3.29834512 |
| 6 | MAP3K9 | 3.26413291 |
| 7 | EPHA4 | 3.14685678 |
| 8 | NTRK3 | 3.02912579 |
| 9 | MAP2K7 | 2.88728826 |
| 10 | ACVR1B | 2.61387803 |
| 11 | MAPKAPK3 | 2.59465535 |
| 12 | TEC | 2.39406914 |
| 13 | MYLK | 2.39175175 |
| 14 | MARK1 | 2.37114141 |
| 15 | MAPK13 | 2.30742282 |
| 16 | MINK1 | 2.28478361 |
| 17 | BMX | 2.21905017 |
| 18 | PLK2 | 2.07087228 |
| 19 | STK39 | 2.06619320 |
| 20 | GRK6 | 2.03933631 |
| 21 | DAPK2 | 2.00351636 |
| 22 | ARAF | 1.84662604 |
| 23 | FRK | 1.83012645 |
| 24 | BTK | 1.78971296 |
| 25 | EIF2AK1 | 1.77902644 |
| 26 | CDK19 | 1.74150621 |
| 27 | WNK4 | 1.67587681 |
| 28 | PNCK | 1.65529126 |
| 29 | STK16 | 1.62751039 |
| 30 | MAP2K4 | 1.62030736 |
| 31 | KSR1 | 1.60294849 |
| 32 | PRPF4B | 1.58422531 |
| 33 | OXSR1 | 1.56750255 |
| 34 | GRK5 | 1.46423566 |
| 35 | FES | 1.45413191 |
| 36 | CAMK2B | 1.45059743 |
| 37 | MAP3K12 | 1.43847287 |
| 38 | PAK6 | 1.42587421 |
| 39 | PAK3 | 1.42068631 |
| 40 | RIPK4 | 1.40567170 |
| 41 | IKBKB | 1.39390977 |
| 42 | CSF1R | 1.38939471 |
| 43 | NTRK2 | 1.31494445 |
| 44 | PIK3CG | 1.31484951 |
| 45 | TRPM7 | 1.31070538 |
| 46 | PRKCG | 1.28976130 |
| 47 | DYRK1A | 1.27291713 |
| 48 | CAMK2A | 1.26154983 |
| 49 | CAMK2D | 1.23836267 |
| 50 | ERBB3 | 1.22457590 |
| 51 | NME1 | 1.21693170 |
| 52 | KSR2 | 1.21142653 |
| 53 | CDK5 | 1.20422200 |
| 54 | EPHA2 | 1.20093453 |
| 55 | DAPK1 | 1.15018973 |
| 56 | MAP3K13 | 1.14831144 |
| 57 | SYK | 1.14629034 |
| 58 | ZAP70 | 1.13955867 |
| 59 | ILK | 1.11449812 |
| 60 | GRK1 | 1.10254797 |
| 61 | PHKG1 | 1.09834519 |
| 62 | PHKG2 | 1.09834519 |
| 63 | TBK1 | 1.06709371 |
| 64 | CDK14 | 1.06446805 |
| 65 | TNIK | 1.06273486 |
| 66 | MAPKAPK5 | 1.05581775 |
| 67 | CAMKK2 | 1.04682954 |
| 68 | WNK1 | 1.04497813 |
| 69 | MAP2K2 | 1.00515978 |
| 70 | CCNB1 | 0.99332548 |
| 71 | STK3 | 0.98179975 |
| 72 | CDK18 | 0.98076329 |
| 73 | STK38 | 0.97929739 |
| 74 | AKT3 | 0.97065465 |
| 75 | IKBKE | 0.97014095 |
| 76 | NTRK1 | 0.95349629 |
| 77 | TLK1 | 0.93373785 |
| 78 | CDK15 | 0.93236437 |
| 79 | CSNK1G2 | 0.93230137 |
| 80 | MUSK | 0.90370007 |
| 81 | SGK494 | 0.90064310 |
| 82 | SGK223 | 0.90064310 |
| 83 | ERBB2 | 0.88460967 |
| 84 | CAMKK1 | 0.87575597 |
| 85 | MAP3K2 | 0.86309373 |
| 86 | FER | 0.84566987 |
| 87 | NEK9 | 0.83204086 |
| 88 | ITK | 0.83139778 |
| 89 | STK38L | 0.82691824 |
| 90 | LYN | 0.81273214 |
| 91 | CDK11A | 0.81164545 |
| 92 | CSNK1G3 | 0.79735779 |
| 93 | CAMK2G | 0.79484646 |
| 94 | LMTK2 | 0.79065750 |
| 95 | PTK2B | 0.78577116 |
| 96 | IRAK1 | 0.77963440 |
| 97 | TNK2 | 0.77089300 |
| 98 | TXK | 0.76006627 |
| 99 | RAF1 | 0.74071744 |
| 100 | PIM2 | 0.73724564 |
| 101 | MAP3K1 | 0.73562557 |
| 102 | MAP4K2 | 0.73057478 |
| 103 | PRKCE | 0.72494699 |
| 104 | LATS2 | 0.69286971 |
| 105 | ROCK2 | 0.65801677 |
| 106 | SIK2 | 0.65724276 |
| 107 | HCK | 0.65174030 |
| 108 | CSK | 0.65122051 |
| 109 | PAK1 | 0.65093108 |
| 110 | ADRBK2 | 0.64259398 |
| 111 | TYRO3 | 0.62848355 |
| 112 | PRKD1 | 0.61825488 |
| 113 | UHMK1 | 0.60436563 |
| 114 | ERBB4 | 0.59706421 |
| 115 | STK11 | 0.59179742 |
| 116 | MAPK12 | 0.58657644 |
| 117 | PRKD3 | 0.58473836 |
| 118 | BRAF | 0.58414835 |
| 119 | EIF2AK3 | 0.54925726 |
| 120 | MAPK10 | 0.54656077 |
| 121 | NUAK1 | 0.54234420 |
| 122 | STK10 | 0.53575248 |
| 123 | BMPR1B | 0.52598463 |
| 124 | BMPR2 | 0.51882795 |
| 125 | SGK2 | 0.51360444 |
| 126 | PRKCH | 0.50632259 |
| 127 | PDPK1 | 0.50283437 |
| 128 | FGR | 0.49552411 |
| 129 | PKN1 | 0.47845343 |
| 130 | MKNK2 | 0.47147871 |
| 131 | MAP2K1 | 0.46650758 |
| 132 | ALK | 0.46414543 |
| 133 | PRKCZ | 0.45990886 |
| 134 | FLT3 | 0.45768081 |
| 135 | BCR | 0.45559278 |
| 136 | CAMK1 | 0.44992443 |
| 137 | BLK | 0.44789974 |
| 138 | PRKCQ | 0.43808640 |
| 139 | WNK3 | 0.42768538 |
| 140 | MAP3K6 | 0.42514034 |
| 141 | TAF1 | 0.42140815 |
| 142 | PRKCI | 0.41989331 |
| 143 | DAPK3 | 0.41961255 |
| 144 | ADRBK1 | 0.41629633 |
| 145 | PRKCD | 0.41509278 |
| 146 | ABL1 | 0.40599534 |
| 147 | CSNK1G1 | 0.40224500 |
| 148 | IGF1R | 0.39657086 |
| 149 | ZAK | 0.39002797 |
| 150 | STK24 | 0.37831474 |
| 151 | TESK2 | 0.37437378 |
| 152 | PRKG1 | 0.37239703 |
| 153 | PDK1 | 0.37149479 |
| 154 | PINK1 | 0.36755130 |
| 155 | HIPK2 | 0.36750325 |
| 156 | PIM1 | 0.36687472 |
| 157 | SGK3 | 0.34717726 |
| 158 | STK4 | 0.31917501 |
| 159 | PRKCA | 0.31692468 |
| 160 | MATK | 0.31437679 |
| 161 | EPHA3 | 0.30142489 |
| 162 | MAP3K3 | 0.29844866 |
| 163 | MAP3K7 | 0.29180445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 4.68081909 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.37264172 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.29038375 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.12238258 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 3.03599512 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.96182877 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.95507298 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72421864 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.52671285 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.49368385 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48028453 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.46004325 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41038412 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37183528 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.34182066 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32771195 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28769051 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.27447178 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.20300117 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 2.15844653 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14559877 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.12322786 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02184251 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00439618 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.99701263 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.97878035 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.96873102 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.89086745 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87829152 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87440303 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82605558 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.81505819 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80979395 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.79982655 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.78417068 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.77095579 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.75216147 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74202115 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.72499369 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72192153 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71372582 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71082468 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67896816 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67644521 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.66704144 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.65741675 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61085106 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52539348 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.50700156 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49720967 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48827025 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47221329 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.44749727 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.44227832 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41020200 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.39411835 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36777401 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36369316 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30553217 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24862089 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19864468 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19437983 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17319269 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16583624 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11783763 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07308346 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05033109 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 1.02372253 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01519634 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 1.01330455 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96449222 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94930016 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90687646 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88898648 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88766727 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87114074 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.84567771 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84280887 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84208709 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83666049 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82357515 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81076450 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80654468 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79863986 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78757919 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78204666 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75027684 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73692547 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72538587 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71201132 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.70646662 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70493163 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68692008 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66909757 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66880651 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.66719229 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63656443 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62170164 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62041851 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60933236 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59277291 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59203869 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58909084 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58512853 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58065129 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56391331 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54688194 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53879134 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53474271 |
| 110 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53118494 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51652179 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51386408 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50625729 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50205538 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46914754 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46030068 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45816852 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45460976 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45093298 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44905152 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44877690 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43808944 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43586550 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43474342 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43438277 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41676584 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41542048 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.40925235 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40207417 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.39438713 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38935592 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38513366 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37969860 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36711858 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34346474 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34123607 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33433332 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31772780 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31695007 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30915446 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30580221 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.30014447 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29864165 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29766904 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29355659 |
| 146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28115007 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.28026182 |
| 148 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27957860 |
| 149 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27418966 |
| 150 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.26597768 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25113753 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24916927 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.24024674 |
| 154 | Melanoma_Homo sapiens_hsa05218 | 0.23956296 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.22355389 |
| 156 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20619321 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18677537 |
| 158 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18492443 |
| 159 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.18336085 |
| 160 | Purine metabolism_Homo sapiens_hsa00230 | 0.17458409 |
| 161 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17005131 |
| 162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14492139 |
| 163 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13911023 |
| 164 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13892310 |
| 165 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12487713 |

